Seer, Inc. (SEER)
$2.04+0.49%Close
SELLRECOVERY · day 20
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $112M
- Avg volume
- 876.3K
- Beta
- 1.52
- P/E (TTM)
- -1.67
- Short % float
- 0.45%
- Days to cover
- 1.0
- SI change
- +22.6%
- 1W
- +0.49%
- 1M
- +3.55%
- 3M
- +13.97%
- YTD
- +12.09%
- vs SPY 1W
- +1.68%
- vs SPY 1M
- +0.23%
- vs SPY 3M
- +11.58%
- vs SPY YTD
- +0.33%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SPOKSELLSpok Holdings, Inc.RECOVERYQ 13$10.62+3.01%
- AKBASELLAkebia Therapeutics, Inc.CRISISQ -14$0.90-1.10%
- ACIUBUYAC Immune S.A.RECOVERYQ -2$2.86-1.38%
- CYTKSELLCytokinetics, IncorporatedBEARQ 9$77.09+0.33%
- TXMDSELLTherapeuticsMD, Inc.RECOVERYQ -2$2.07+0.49%
- VSTMBUYVerastem, Inc.RECOVERYQ 3$6.86-0.44%
- BBIOSELLBridgeBio Pharma, Inc.RECOVERYQ 20$81.07-0.53%
- CDIOBUYCardio Diagnostics Holdings, Inc.CRISISQ -18$1.93-4.93%
- EVOBUYEvotec SECRISISQ 15$1.89-2.07%
- FEEDBUYENvue Medical, Inc.CRISISQ -17$0.40+2.56%
- HCTISELLHealthcare Triangle, Inc.CRISISQ -27$0.84-4.55%
- ENSCBUYEnsysce Biosciences, Inc.CRISISQ -25$0.36-2.70%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRBUYKymera Therapeutics, Inc.$10.0BBULLQ 27$121.38+1.04%
- NRIXBUYNurix Therapeutics, Inc.$2.8BBULLQ 13$26.93-1.68%
- PHVSBUYPharvaris N.V.$2.5BBULLQ 17$36.10+2.87%
- MLYSSELLMineralys Therapeutics, Inc.$2.3BRECOVERYQ 21$26.61-1.48%
- ORICBUYORIC Pharmaceuticals, Inc.$1.4BBULLQ 4$13.92-5.21%
- CGEMBUYCullinan Therapeutics, Inc.$1.3BBULLQ 6$20.84+0.65%
- GLUESELLMonte Rosa Therapeutics, Inc.$1.3BCRISISQ 10$15.03-3.64%
- SANABUYSana Biotechnology, Inc.$1.0BRECOVERYQ -4$3.63-3.32%
- STTKBUYShattuck Labs, Inc.$673MRECOVERYQ 7$7.45+4.91%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 10
- GROWTH
- 20
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-16.3%
REV YoY-
ROE-27.2%
EPS YoY-
ROA-26.5%
GROSS46
OP-511
NET-491
[VALUATION]
P/E TTM-1.67
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.50
P/FCF-
EV/EBITDA-1.69
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E9.92
ALTMAN Z-
CURR RATIO14.74
ND/EBITDA-
BETA1.52



















